Background and purposeelevated serum levels of brain natriuretic peptide bnp have been associated with cardioembolic stroke and increased poststroke mortality. Prognostic value of plasma neuroendocrine biomarkers in. Background and purpose hyponatremia has been shown in association with cerebral vasospasm cvs following aneurysmal subarachnoid hemorrhage sah. Brain natriuretic peptide bnp is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive to cite. Stroke types in acute ischemic stroke kensaku shibazaki, kazumi kimura, yasuyuki iguchi, yoko okada and takeshi inoue abstract background plasma brain natriuretic peptide bnp is used as a marker of congestive heart failure. Most patients with ischemic stroke and af have a high chadsvasc score. All patients presenting with an ischemic stroke or a tia were included after. Sincethe discoveryofatrial natriuretic peptide anp in the heart 15 and subsequently in the brain 510, anphas been implicated inbodyfluid homeostasis andbloodpressure. Background circulating btype natriuretic peptide bnp concentrations strongly predict mortality in patients with heart failure hf. Syncope is a common condition that accounts for 3% of emergency department ed visits and 16% of hospital admissions. The normal values listed herecalled a reference rangeare just a guide. Nps can reduce brain oedema and have a neuroprotective role in acute ischemic stroke as well as during recovery after stroke.
Natriuretic peptide, brain subject areas on research a canadian context for the acute study of clinical effectiveness of nesiritide and decompensated heart failure ascendhf trial. Atrial natriuretic peptides anps consist of a family of peptides which are synthesized and then stored as three different prohormones i. This study investigated the role of bnp determination in a cohort of elderly patients admitted to hospital with acute decompensated hf and its correlation with main demographic, clinical, and instrumental data and evaluated possible association with major outcome. Btype natriuretic peptide as a marker for heart failure in. Levels of brain natriuretic peptide are associated with. Brain natriuretic peptide bnp is a peptide produced predominantly by the cardiac ventricles and in lesser quantities by the atria. Brain natriuretic peptide bnp is believed to be a diagnostic marker for cardiovascular diseases, including atrial fibrillation. Blood volume and brain natriuretic peptide in congestive. Human brain natriuretic peptide bnp or nesiritide to help. We sought to determine whether ntprobnp levels were associated with functional outcomes after ais. Longterm functional outcome after stroke is one of the most important and difficult variables to predict, 1, 2 and is subject to complex interactions with multiple factors including age, gender, ethnicity, preexisting morbidity, stroke severity, acute interventions, and poststroke care. The prognostic value of ntprobnp in acute ischemic stroke is limited and remains controversial.
For the prediction of functional outcome or stroke recurrence both markers. Furthermore, we examined the relationship between bnp and various clinical characteristics incorporated into an established survival model used for risk stratification. Nterminal pro brain natriuretic peptide ntprobnp predicts poor outcome in cardiovascular disease. Plasma brain natriuretic peptide as an independent predictor of in hospital mortality after acute ischemic stroke kensaku shibazaki 1, kazumi kimura 1, yoko okada 1, yasuyuki iguchi 1, jyunichi uemura 1, yuka terasawa 1, junya aoki 1.
Jul 01, 2009 4 jourdain p, jondeau g, funck f, gueffet p, le helloco a, donal e, aupetit jf, aumont mc, galinier m, eicher jc, cohensolal a, juilliere y. Dec 11, 2008 cardioembolic stroke generally results in more severe disability, since it typically has a larger ischemic area than the other types of ischemic stroke. Stroke is a major cause of longterm disability and death. Objective to validate midregional proatrial natriuretic peptide mrproanp for outcome prediction and diagnosis of cardioembolic stroke etiology compared to established clinical variables.
Methods in this prospective multicenter cohort study, we quantified mrproanp levels in ischemic stroke patients within 24 hours of onset. Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction. Value of brain natriuretic peptide after acute myocardial infarctionakut miyokard infarktusu sonrasi beyin natriuretik peptidin degeri. Tertiary hospital, neurosciences critical care unit and stroke unit. After removing stroke severity, therapeutic anticoagulation was also associated with stroke prognosis or 0. Stroke with hypertension, stroke without hypertension, and hypertension alone. Background plasma brain natriuretic peptide bnp is used as a marker of congestive heart failure. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Brain natriuretic peptide bnp is a 32 amino acid polypeptide secreted by the ventricles of the heart in response to excessive stretching of heart muscle cells.
Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or tia j neurol sci, 260 2007, pp. Plasma brain natriuretic peptide as an independent predictor. Objectives the purpose of this study was to examine the prognostic value of midregional proatrial natriuretic peptide mr proanp in patients with acute ischemic stroke. Brain type natriuretic peptide bnp or ntprobnp testing has been proposed as an adjunct to other clinical testing in numerous clinical situations including, but not limited to, to aid in the diagnosis of patients presenting to the emergency department with acute dyspnea, monitor response to treatment for heart failure, and as a. Plasma brain natriuretic peptideguided therapy to improve outcome in heart failure. Brain natriuretic peptide could be a biomarker for. Health, general heart attack diagnosis prognosis research risk factors heart failure natriuretic peptides.
Brain natriuretic peptide in acute ischemic stroke. The determination of btype natriuretic peptides bnp may have a role in the diagnosis of heart failure hf or guiding hf therapy. In this study, we attempt to ascertain the difference in the prognostic value of nterminal probtype natriuretic peptide ntprobnp between cardioembolic and noncardioembolic stroke. We sought to determine whether ntprobnp at admission were associated with shortterm functional outcome after acute ischemic stroke. Objectives using a prospective study design, we assessed the value of brain natriuretic peptide bnp to identify patients with heart failure who have an increased risk of deterioration of their functional status. Nterminal pro brain natriuretic peptide ntprobnp levels are frequently elevated in patients with acute ischemic stroke. Midregional proatrial natriuretic peptide and outcome in. You may use the following reference to interpret the readings. Nov 16, 2017 a brain natriuretic peptide bnp test measures the amount of the bnp hormone in the blood.
Because btype natriuretic peptide is a powerful predictor of heart failure, its capability to predict a fatal outcome in stroke might be limited to the cardioembolic stroke subtype. Longterm functional outcome after stroke is one of the most important and difficult variables to predict 1,2 and is subject to complex interactions with multiple factors, including age, gender, ethnicity, preexisting morbidity, stroke severity, acute interventions, and poststroke care. Brain natriuretic peptide novel cardiac natriuretic. The future of heart failure diagnosis, therapy, and management. Bnp has been shown to be a useful screening and prognostic tool in patients with heart failure and is typically found to be increased in patients with left ventricular dysfunction. Rapid measurement of btype natriuretic peptide in the emergency diagnosis of heart failure. Independent of stroke severity, chadsvasc score is associated with 3month outcome. Bnp values normally increase with age but may stay within a normal range unless heart failure is present. Plasma brain natriuretic peptide can be a biological marker. Role of brain natriuretic peptide as a novel prognostic biomarker in. Mar 27, 2012 measuring the values of brain natriuretic peptide or bnp test. Elevated brain natriuretic peptide levels in chronic fatigue. Moreover, plasma bnp levels are increased in patients with acute ischemic stroke, in particular, cardioembolic stroke. Nterminal pro brain natriuretic peptide ntprobnp has been shown to be associated with the prognosis of cardiovascular diseases and ntprobnp level is elevated in patients with acute ischemic stroke.
The role of bnp and nterminal of the prohormone bnp ntprobnp as. Brain natriuretic peptide among stroke patients europe. Serum btype natriuretic peptide level and timing of its measurement. Consecutive patients with acute ischemic or hemorrhagic stroke who were evaluated for hf. In this study, we evaluated the levels of plasma brain natriuretic peptide in acute ischemic stroke. A new metaanalysis has shown that levels of btype natriuretic peptide bnp are associated with poststroke mortality independent of stroke severity, age, and sex. The role of bnp and nterminal of the prohormone bnp. Plasma nterminal prohormone of brain natriuretic peptide ntprobnp, ddimer, creactive protein, serum albumin, and globulin levels have been. The present study investigated whether baseline plasma brain natriuretic peptide bnp, n. Evaluation of these enzymes represents a simple method for the ischemic stroke subtype diagnosis and prognosis. Brain natriuretic peptide in acute ischemic stroke request pdf. Brain natriuretic peptide predicts functional outcome in ischemic stroke. The aim of our study was to assess the potential relationship between bnp levels and pad among t2dm patients.
Value of brain natriuretic peptide after acute myocardial. Cardiac troponins and nterminal probrain natriuretic peptide in. Using a singlecenter cohort of 362 patients with ischemic stroke, they found that mrproanp levels were associated with severity of stroke, history of heart failure, and atrial. This study suggests that an elevated brain natriuretic peptide at hospital admission for ischemic stroke is independently associated with poorer functional outcome at six months. Plasma brain natriuretic peptide can be a biological. Apr 22, 2020 data from maisel as, krishnaswamy p, nowak rm, et al. Atrial natriuretic peptides in pathophysiological diseases. Mar 21, 2014 the effects of brain natriuretic peptide bnp on the risk of cardiovascular disease and atherosclerosis have been studied.
We sought to determine whether bnp levels were associated with functional outcome after ischemic stroke. The prognostic value of the namino terminal fragment of the prohormone brain natriuretic peptide ntprobnp in acute ischemic stroke ais is uncertain. Jan 01, 2018 elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction. Background the rapid and reliable estimation of prognosis in acute ischemic stroke is pivotal to. Cardiac troponin ctn, the brain natriuretic peptide bnp, and the nterminal. Outcome prediction for patients with anterior circulation. Request pdf association between increased nterminal pro brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke background and purpose nterminal pro brain. This study aimed to determine the role of brain natriuretic peptide. The effect of natriuretic peptides and bradykinin on. Brain natriuretic peptide levels rise in response to stretch of ventricular myocytes or increases in wall tension as occurs in congestive heart failure chf. Plasma brain natriuretic peptide as a biochemical marker of high left. Difference in the prognostic significance of nterminal probtype. Association of plasma brain natriuretic peptide levels in.
The purpose of this study was to examine the prognostic value of midregional proatrial natriuretic peptide mrproanp in patients with acute ischemi. Serum levels of brain natriuretic peptide bnp show a significant correlation with mortality and longterm functional outcomes after cardioembolic stroke, according to a large, prospective cohort. Role of brain natriuretic peptide in risk stratification of. Zhuang meiting,he xinwei,zhao rong correlation between plasma brain natriuretic peptide and functional outcome after intravenous thrombolysis in patients with acute ischemic stroke j. Utility of brain natriuretic peptide assay as a predictor of. The epub format uses ebook readers, which have several ease of reading features. Early etiologic diagnosis of ischemic stroke subtype guides acute management and treatment. Plasma brain natriuretic peptide as a surrogate marker for. However, little information is available regarding peripheral arterial disease pad, particularly among subjects with type2 diabetes mellitus t2dm. However, the association between ntprobnp and poor prognosis after ischemic stroke is still uncertain. Correlation between plasma brain natriuretic peptide and. Both cardiac and extracardiac stimuli influence bnp levels, suggesting that bnp might have similar prognostic value in patients without hf. Brain natriuretic peptide cardiology related questions answered. Risk factors, outcome, and treatment in subtypes of ischemic stroke.
Correlation between btype natriuretic peptide and functional. In the past few years there has been increasing evidence that brain natriuretic peptide bnp is responsible for natriuresis after sah. Plasma bnp levels was significantly elevated in patients with ischemic stroke. Sir, we read with interest the article by zeynep cakir and colleagues on brain natriuretic peptide bnp in stroke or hypertension patients, and wish to share a few opinions about the use of bnp among acute ischemic stroke ais patients in the emergency department ed. At present, the use of plasma biomarkers during the point of care testing poct is getting increasing popular. Chadsvasc score and prognosis in ischemic strokes with. Brain natriuretic peptide or bnp is a substance secreted from the ventricles or lower chambers of the heart as a response to changes in pressure resulting from the development of heart failure or at various stages of heart failure. The brain is a productive source of a variety of enzymes and any brain injury like a stroke to brain tissue could similarly result in an increase in these enzymes in cerebrospinal fluid and serum. Nterminal probrain natriuretic peptide levels as a. We diagnosed patients with ischemic stroke when they had a rapid onset of focal brain.
Bnp is a marker of poor outcome in patients with ischemic stroke 1. Utility of brain natriuretic peptide assay as a predictor of short term outcomes in patients presenting with syncope to the emergency department background. An interesting group of patients was highlighted who have almost completely normal invasive hemodynamic measures at rest including normal brain natriuretic peptide levels but who develop very abnormal hemodynamics only during exercise. Elevated serum levels of brain natriuretic peptide bnp have been associated with cardioembolic ce stroke and increased poststroke mortality.
The primary predictor variable was functional outcome evaluated by modified rankin scale. Original investigationorijinal arastirma, clinical report by the anatolian journal of cardiology anadolu kardiyoloji dergisi. Objectives the aim of this study was to compare the prognostic value of bnp between patients with and those without hf. Elevated serum levels of brain natriuretic peptide bnp have been associated with cardioembolic ce stroke and increased post stroke mortality methods. Elevated serum levels of brain natriuretic peptide bnp, a powerful predictor of outcomes in patients with cardiovascular disease, 11 have been associated with atrial fibrillation af, 14 cardioembolic ce stroke, 15, 16 and higher post stroke mortality. Opinions about the use of brain natriuretic peptide among. Difference in the prognostic significance of nterminal. We aim to evaluate if plasma biomarkers can predict stroke subtypes in the early phase from stroke onset. This study was conducted on 96 patients with acute ischemic stroke.
Discussion in biomedical mecfs research started by sly saint, jan 1, 2018. Btype natriuretic peptide levels and mortality in patients. The present study aimed to use outcome related factors derived from biochemical, imaging and clinical data to establish a logistic regression model that can predict the outcome of patients with ais following endovascular treatment evt. Association between increased nterminal pro brain natriuretic peptide level and poor clinical outcomes after acute ischemic stroke author links open overlay panel jingyuan yang a b 1 chongke zhong a c 1 aili wang a tan xu a xiaoqing bu a c yanbo peng d jinchao wang e hao peng a qunwei li f zhong ju g deqin geng h yonghong zhang a jiang he c on. Because btype natriuretic peptide is a powerful predictor of heart failure. The relationships between plasma levels of brain natriuretic peptide bnp and severity and location of stroke, prognosis, and infarct volume were investigated in acute ischemic. Brain natriuretic peptide bnp is believed to be a diagnostic marker for cardiovascular diseases, including atrial fibrillation af.
However, it is difficult to differentiate cardioembolic stroke from noncardioembolic stroke atherothrombotic stroke and lacunar stroke. Brain natriuretic peptide predicts functional outcome in ischemic stroke, stroke, vol. Bnp but not sctnln is associated with cardioembolic aetiology and. Brain natriuretic peptide predicts functional outcome in ischemic stroke article in stroke 432. Brainheart axis and biomarkers of cardiac damage and. Nt probnp and 6month mortalityfunctional outcome in each group. Brain natriuretic peptide and nterminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. We investigated whether the plasma bnp level can also be used as a biological marker to differentiate specific stroke subtype, in particular cardioembolic stroke. Rost ns1, biffi a, cloonan l, chorba j, kelly p, greer d, ellinor p, furie kl. Jan 08, 2018 lainchbury jg, campbell e, frampton cm, et al.
Plasma brain natriuretic peptide in the outpatient setting. Elevated plasma brain natriuretic peptide levels predict left atrial appendage dysfunction in patients with acute ischemic stroke. Any reading from 100 900 pgml is considered abnormal and can indicate heart failure at varying levels of severity. Inflammation and activation of the neuroendocrine systems comprise important aspects of stroke pathophysiology. It has been recently shown that humans without functional natriuretic peptides nps suffer from massive stokes 1, 2. Ddimer and brain natriuretic peptide bnp are reported as markers of active. Human brain natriuretic peptide bnp or nesiritide to help heart, kidney and humoral function. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Natriuretic peptides and mortality after stroke request pdf.
Brain natriuretic peptide and cerebral vasospasm in. Brain natriuretic peptide, nonvalvular atrial fibrillation, stroke, outcome, modified rankin scale score, systolic blood pressure, national institutes of health stroke scale introduction nonvalvular atrial fibrillation nvaf is an important risk factor for ischemic stroke especially in the elderly, and is a major cause of. Brain natriuretic peptide is a powerful predictor of. Brain natriuretic peptide in acute ischemic stroke article in journal of stroke and cerebrovascular diseases. Materials and methods subjects the study population consisted of 153 consecutive patients presenting with symptoms of acute stroke who abstract background. Philip kistler stroke research center, massachusetts general hospital, 175 cambridge street, suite 300, boston, ma 02114, usa. Nterminal probrain natriuretic peptide and shortterm. Can brain natriuretic peptide predict the outcome in patients. Nterminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke article in neuroreport 25. Brain natriuretic peptide predicts functional outcome in. Methodswe measured bnp in consecutive patients aged 18 years admitted to. We analyzed the prognostic value of btype natriuretic peptide bnp and.
73 1617 1493 1118 632 1150 1471 45 30 1617 1570 365 1518 727 423 1652 341 691 1423 200 1163 57 278 1575 866 586 795 204 740 1276 115 1010 1127 1222 314 955 511 1022 1437 29 1104 206 860 623